WASHINGTON – Congressman David G. Valadao (CA-22) recently joined Congressman John Duarte (CA-13) to introduce the Valley Fever Awareness and Vaccine Development and Manufacturing Act. The legislation aims to address the pressing need for a human vaccine for Valley Fever by supporting the development, approval, licensing, and initial manufacturing of a vaccine.

“Valley Fever has a huge impact on communities throughout the Central Valley and leaves thousands of people sick every year,” said Congressman Valadao. “I’m proud to support Congressman Duarte’s legislation to prioritize the development of a Valley Fever vaccine to combat the spread of this disease and save lives. As a member of the Valley Fever Task Force, I’ll continue working toward solutions to keep Central Valley families safe and healthy.”

"Valley Fever is a growing public health threat in our communities, and this bill is a critical step toward developing the first human vaccine to protect those most at risk," said Congressman Duarte. "I’m proud to lead this effort and work with local and national partners to tackle this disease head-on and bring much-needed relief to the Central Valley and other affected regions."

Background:

Congressman Valadao is a member of the Valley Fever Task Force, which was founded in 2013. The Task Force is committed to raising awareness and advancing policies to combat Valley Fever. Congressman Valadao has been a member since its founding. Last year, Congressman Valadao participated in a Valley Fever Roundtable hosted by the Task Force to discuss ongoing treatment and vaccine developments. The roundtable included medical experts, researchers, and advocates focused on combatting Valley Fever. He’s also a co-sponsor of the FORWARD Act, which supports various research and development programs with the goal of developing new drugs, treatments, and vaccines to combat Valley Fever.

###